APA (7th ed.) Citation

VK, P., J, W., Y, Y., TS, A., E, V., J, X., . . . MR, G. (2020). A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Neuro-oncology, 22(10), 1505. https://doi.org/10.1093/neuonc/noaa062

Chicago Style (17th ed.) Citation

VK, Puduvalli, et al. "A Bayesian Adaptive Randomized Phase II Multicenter Trial of Bevacizumab with or Without Vorinostat in Adults with Recurrent Glioblastoma." Neuro-oncology 22, no. 10 (2020): 1505. https://doi.org/10.1093/neuonc/noaa062.

MLA (9th ed.) Citation

VK, Puduvalli, et al. "A Bayesian Adaptive Randomized Phase II Multicenter Trial of Bevacizumab with or Without Vorinostat in Adults with Recurrent Glioblastoma." Neuro-oncology, vol. 22, no. 10, 2020, p. 1505, https://doi.org/10.1093/neuonc/noaa062.